first glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes The New Longevity Drug Isn't

A clinical trial of Novo Nordisks Wegovy found that it helped users lose about 15% of their body weight over 68 weeks

A nurse or doctor inserts a small IV line and slowly drips a glutathione solution into your vein (often mixed with saline and nutrients)

It demonstrates no tolerance development meaning effectiveness doesnt diminish over time, no rebound insomnia upon discontinuation, and no dependency issues

In the context of critical limb ischemia (CLI) in murine models, TB-500 appears to have pro-angiogenic potential, as suggested by researchers

They're lower risk, support overall health, and can be maintained long-term as part of a healthy lifestyle